Navigation auf zora.uzh.ch
ZORA will change to a new software on 8th September 2025. Please note: deadline for new submissions is 21th July 2025!
Information & dates for training courses can be found here: Information on Software Migration.
Raeber, Miro E; Sahin, Dilara; Boyman, Onur (2022). Interleukin-2–based therapies in cancer. Science Translational Medicine, 14(670):abo5409.
Molecular insights into the mechanism of beneficial and adverse effects of interleukin-2 (IL-2) have resulted in the development of improved IL-2 formulations with IL-2 receptor bias and tissue-targeting properties. Several of these compounds are currently in clinical development and are ushering IL-2 therapy into the current era of cancer immunotherapy.
| Item Type: | Journal Article, refereed, further contribution |
|---|---|
| Communities & Collections: | 04 Faculty of Medicine > University Hospital Zurich > Clinic for Immunology |
| Dewey Decimal Classification: | 610 Medicine & health |
| Scopus Subject Areas: | Health Sciences > General Medicine |
| Uncontrolled Keywords: | General Medicine |
| Language: | English |
| Date: | 9 November 2022 |
| Deposited On: | 01 Feb 2023 09:16 |
| Last Modified: | 27 Jun 2025 01:35 |
| Publisher: | American Association for the Advancement of Science |
| ISSN: | 1946-6234 |
| OA Status: | Closed |
| Publisher DOI: | https://doi.org/10.1126/scitranslmed.abo5409 |
| PubMed ID: | 36350987 |
Raeber, Miro E